Rapid Novor Inc is the world’s leader in antibody protein sequencing technology. Specializing in the field of mass spectrometry-based proteomics, the company has developed the technology to directly sequence the antibody proteins without necessity of cell line. Rapid Novor has its analysis software with its own intellectual property and an industry-leading mass spectrometry laboratory. So far, the company's laboratory has four advanced mass spectrometers and has become the largest private proteomic mass spectrometry laboratory in Ontario, Canada, which has provided high-quality professional services to hundreds of customers worldwide. Rapid Novor's protein sequencing technology has broad application prospects in the fields of drug development, antibody engineering, and personalized diagnosis and treatment!